|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
|
|
2
|
Albulescu A, Plesa A, Fudulu A, Iancu IV,
Anton G and Botezatu A: Epigenetic approaches for cervical
neoplasia screening (review). Exp Ther Med. 22:14812021. View Article : Google Scholar
|
|
3
|
Poulet G, Massias J and Taly V: Liquid
biopsy: General concepts. Acta Cytologica. 63:449–455. 2019.
View Article : Google Scholar
|
|
4
|
De Rubis G, Rajeev Krishnan S and Bebawy
M: Liquid biopsies in cancer diagnosis, monitoring, and prognosis.
Trends Pharmacol Sci. 40:172–186. 2019. View Article : Google Scholar
|
|
5
|
Dasari S, Wudayagiri R and Valluru L:
Cervical cancer: Biomarkers for diagnosis and treatment. Clin Chim
Acta. 445:7–11. 2015. View Article : Google Scholar
|
|
6
|
Ma L, Guo H, Zhao Y, Liu Z, Wang C, Bu J,
Sun T and Wei J: Liquid biopsy in cancer current: Status,
challenges and future prospects. Sig Transduct Target Ther.
9:3362024. View Article : Google Scholar
|
|
7
|
Strander B, Andersson-Ellström A, Milsom
I, Rådberg T and Ryd W: Liquid-based cytology versus conventional
Papanicolaou Smear in an organized screening program: A prospective
randomized study. Cancer. 111:285–291. 2007. View Article : Google Scholar
|
|
8
|
Gibson J, Young S, Leng B, Zreik R and Rao
A: Molecular diagnostic testing of cytology specimens: Current
applications and future considerations. J Am Soc Cytopathol.
3:280–294. 2014. View Article : Google Scholar
|
|
9
|
Marrugo-Ramírez J, Mir M and Samitier J:
Blood-based cancer biomarkers in liquid biopsy: A promising
Non-invasive alternative to tissue biopsy. Int J Mol Sci.
19:28772018. View Article : Google Scholar
|
|
10
|
Causin RL, da Silva LS, Evangelista AF,
Leal LF, Souza KCB, Pessôa-Pereira D, Matsushita GM, Reis RM,
Fregnani JHTG and Marques MMC: MicroRNA biomarkers of High-grade
cervical intraepithelial neoplasia in liquid biopsy. Biomed Res
Int. 2021:66509662021. View Article : Google Scholar
|
|
11
|
Aftab M, Poojary SS, Seshan V, Kumar S,
Agarwal P, Tandon S, Zutshi V and Das BC: Urine miRNA signature as
a potential Non-invasive diagnostic and prognostic biomarker in
cervical cancer. Sci Rep. 11:103232021. View Article : Google Scholar
|
|
12
|
van den Helder R, Steenbergen RDM, van
Splunter AP, Mom CH, Tjiong MY, Martin I, Rosier-van Dunné FMF, van
der Avoort IAM, Bleeker MCG and van Trommel NE: HPV and DNA
methylation testing in urine for cervical intraepithelial neoplasia
and cervical cancer detection. Clin Cancer Res. 28:2061–2068. 2022.
View Article : Google Scholar
|
|
13
|
Poljak M, Cuschieri K, Alemany L and
Vorsters A: Testing for human papillomaviruses in urine, blood, and
oral specimens: An update for the laboratory. J Clin Microbiol.
61:e0140322013.
|
|
14
|
Jeannot E, Latouche A, Bonneau C,
Calméjane MA, Beaufort C, Ruigrok-Ritstier K, Bataillon G, Larbi
Chérif L, Dupain C, Lecerf C, et al: Circulating HPV DNA as a
marker for early detection of relapse in patients with cervical
cancer. Clin Cancer Res. 27:5869–5877. 2021. View Article : Google Scholar
|
|
15
|
Gothwal M, Nalwa A, Singh P, Yadav G,
Bhati M and Samriya N: Role of cervical cancer biomarkers p16 and
Ki67 in abnormal cervical cytological smear. J Obstet Gynaecol
India. 71:72–77. 2021. View Article : Google Scholar
|
|
16
|
Pan L, Yan G, Chen W, Sun L, Wang J and
Yang J: Distribution of circulating tumor cell phenotype in early
cervical cancer. Cancer Manag Res. 11:5531–5536. 2019. View Article : Google Scholar
|
|
17
|
Vishnoi A and Rani S: MiRNA Biogenesis and
Regulation of Diseases: An Overview. Rani S: MicroRNA Profiling.
Volume 1509. Springer New York, New York, NY, USA: pp. 1–10. 2017,
https://link.springer.com/protocol/10.1007/978-1-4939-6524-3_1March
28–2022 View Article : Google Scholar
|
|
18
|
He Y, Lin J, Ding Y, Liu G, Luo Y, Huang
M, Xu C, Kim TK, Etheridge A, Lin M, et al: A systematic study on
dysregulated microRNAs in cervical cancer development. Int J
Cancer. 138:1312–1327. 2016. View Article : Google Scholar
|
|
19
|
Causin RL, de Freitas AJA, Trovo Hidalgo
Filho CM, dos Reis R, Reis RM and Marques MMC: A systematic review
of MicroRNAs involved in cervical cancer progression. Cells.
10:6682021. View Article : Google Scholar
|
|
20
|
Wei H, Wen-Ming C and Jun-Bo J: Plasma
miR-145 as a novel biomarker for the diagnosis and radiosensitivity
prediction of human cervical cancer. J Int Med Res. 45:1054–1060.
2017. View Article : Google Scholar
|
|
21
|
Ma G, Song G, Zou X, Shan X, Liu Q, Xia T,
Zhou X and Zhu W: Circulating plasma microRNA signature for the
diagnosis of cervical cancer. Cancer Biomark. 26:491–500. 2019.
View Article : Google Scholar
|
|
22
|
Metcalf GAD: MicroRNAs: Circulating
biomarkers for the early detection of imperceptible cancers via
biosensor and Machine-learning advances. Oncogene. 43:2135–2142.
2024. View Article : Google Scholar
|
|
23
|
Khieu M and Butler SL: High-Grade Squamous
Intraepithelial Lesion of the Cervix. StatPearls Treasure Island
(FL): StatPearls Publishing; 2025, http://www.ncbi.nlm.nih.gov/books/NBK430728/August
28–2025
|
|
24
|
Rao A, Young S, Erlich H, Boyle S,
Krevolin M, Sun R, Apple R and Behrens C: Development and
characterization of the cobas human papillomavirus test. J Clin
Microbiol. 51:1478–1484. 2013. View Article : Google Scholar
|
|
25
|
Neuber AC, Tostes CH, Ribeiro AG,
Marczynski GT, Komoto TT, Rogeri CD, da Silva VD, Mauad EC, Reis RM
and Marques MMC: The biobank of barretos cancer hospital: 14 years
of experience in cancer research. Cell Tissue Bank. 23:271–284.
2022. View Article : Google Scholar
|
|
26
|
R: The R Project for Statistical
Computing. https://www.r-project.org/October
2–2024
|
|
27
|
Wickham H: ggplot2. Springer Cham; Cham,
Switzerland: pp. 24–129. 2016, https://link.springer.com/book/10.1007/978-3-319-24277-4October
2–2024
|
|
28
|
Waggott D, Chu K, Yin S, Wouters BG, Liu
FF and Boutros PC: NanoStringNorm: An extensible R package for the
pre-processing of NanoString mRNA and miRNA data. Bioinformatics.
28:1546–1548. 2012. View Article : Google Scholar
|
|
29
|
Deo A, Carlsson J and Lindlöf A: How to
choose a normalization strategy for miRNA quantitative real-time
(qPCR) arrays. J Bioinform Comput Biol. 9:795–812. 2011. View Article : Google Scholar
|
|
30
|
Laengsri V, Kerdpin U, Plabplueng C,
Treeratanapiboon L and Nuchnoi P: Cervical cancer markers:
Epigenetics and microRNAs. Lab Med. 49:97–111. 2018. View Article : Google Scholar
|
|
31
|
Freitas AJA, Causin RL, Varuzza MB, Calfa
S, Hidalgo Filho CMT, Komoto TT, Souza CP and Marques MMC: Liquid
biopsy as a tool for the diagnosis, treatment, and monitoring of
breast cancer. Int J Mol Sci. 23:99522022. View Article : Google Scholar
|
|
32
|
Adhit KK, Wanjari A, Menon S and K S:
Liquid biopsy: An evolving paradigm for Non-invasive disease
diagnosis and monitoring in medicine. Cureus. 15:e501762023.
|
|
33
|
Xie H, Norman I, Hjerpe A, Vladic T,
Larsson C, Lui WO, Östensson E and Andersson S: Evaluation of
microRNA-205 expression as a potential triage marker for patients
with low-grade squamous intraepithelial lesions. Oncol Lett.
13:35862017. View Article : Google Scholar
|
|
34
|
Martins I, Ribeiro IP, Jorge J, Gonçalves
AC, Sarmento-Ribeiro AB, Melo JB and Carreira IM: Liquid biopsies:
Applications for cancer diagnosis and monitoring. Genes.
12:3492021. View Article : Google Scholar
|
|
35
|
McDonald JS, Milosevic D, Reddi HV, Grebe
SK and Algeciras-Schimnich A: Analysis of circulating microRNA:
Preanalytical and analytical challenges. Clin Chem. 57:833–840.
2011. View Article : Google Scholar
|
|
36
|
Pritchard CC, Kroh E, Wood B, Arroyo JD,
Dougherty KJ, Miyaji MM, Tait JF and Tewari M: Blood cell origin of
circulating microRNAs: A cautionary note for cancer biomarker
studies. Cancer Prev Res (Phila). 5:492–497. 2012. View Article : Google Scholar
|
|
37
|
Witwer KW: Circulating microRNA biomarker
studies: Pitfalls and potential solutions. Clin Chem. 61:56–63.
2015. View Article : Google Scholar
|
|
38
|
Moldovan L, Batte KE, Trgovcich J, Wisler
J, Marsh CB and Piper M: Methodological challenges in utilizing
miRNAs as circulating biomarkers. J Cell Mol Med. 18:371–390. 2014.
View Article : Google Scholar
|
|
39
|
You W, Wang Y and Zheng J: Plasma miR-127
and miR-218 might serve as potential biomarkers for cervical
cancer. Reprod Sci. 22:1037–1041. 2015. View Article : Google Scholar
|
|
40
|
Wang H, Zhang D, Chen Q and Hong Y: Plasma
expression of miRNA-21, −214, −34a, and −200a in patients with
persistent HPV infection and cervical lesions. BMC Cancer.
19:9862019. View Article : Google Scholar
|
|
41
|
Hoelzle CR, Arnoult S, Borém CRM, Ottone
M, Magalhães KCSF, da Silva IL and Simões RT: MicroRNA levels in
cervical cancer samples and relationship with lesion grade and HPV
Infection. Microrna. 10:139–145. 2021. View Article : Google Scholar
|
|
42
|
Cafforio P, Palmirotta R, Lovero D,
Cicinelli E, Cormio G, Silvestris E, Porta C and D'Oronzo S: Liquid
biopsy in cervical cancer: Hopes and pitfalls. Cancers (Basel).
13:39682021. View Article : Google Scholar
|
|
43
|
Weber JA, Baxter DH, Zhang S, Huang DY,
Huang KH, Lee MJ, Galas DJ and Wang K: The MicroRNA spectrum in 12
body fluids. Clin Chem. 56:1733–1741. 2010. View Article : Google Scholar
|
|
44
|
Buus R, Szijgyarto Z, Schuster EF, Xiao H,
Haynes BP, Sestak I, Cuzick J, Paré L, Seguí E, Chic N, et al:
Development and validation for research assessment of Oncotype
DX® Breast Recurrence Score, EndoPredict® and
Prosigna®. NPJ Breast Cancer. 7:152021. View Article : Google Scholar
|
